
660. The Wellness Industry Is Gigantic — and Mostly Wrong
Freakonomics Radio
00:00
Update on GLP-1 drugs
Emanuel outlines GLP-1 benefits, cardiac risk reductions, access problems, and future pricing trends.
Play episode from 35:52
Transcript

Emanuel outlines GLP-1 benefits, cardiac risk reductions, access problems, and future pricing trends.